Navigating Cloud Migration in the New Normal
In the current business climate, organizations are under dual mandates to both migrate rapidly to the cloud as well as to modernize and embrace cloud-native. During this online presentation and Q&A discussion, we will explore effective strategies, challenges, and opportunities to make the shift amid an evolving landscape.
Join FPT’s guest speakers Bill Martorelli, Principal Analyst at Forrester Research and Kal Patel, MD, CEO & Co-Founder at BrightInsight to discuss the global cloud market changes and outline the impact of cloud migration in the new normal.
- Mr. Bill Martorelli Principle Analyst, Forrester
- Mr. Son Ngoc Nguyen VP of Cloud CoE, FPT Software
- Build resilience during climate
- Kal Patel, MD CEO & Co-Founder, BrightInsight
- Moderator: Mr. Andrej Zdravkovic Senior Vice President, Intellinet
Bill has more than 15 years of experience in technology and business consulting. He came to Forrester with the acquisition of Giga Information Group. At Giga, Bill was responsible for a variety of sourcing research topics, including managed services, IT outsourcing, and hosting.
Bill has written numerous groundbreaking reports on service delivery issues and trends and has delivered many well-received presentations on a variety of topics, including successful application outsourcing and business process outsourcing strategies.
He has been quoted frequently in both industry and business publications, including BusinessWeek, The Wall Street Journal, Financial Times, Investor’s Business Daily, and the Financial Post.
Prior to joining BrightInsight he was Chief Commercial Officer for Doctor on Demand, now the nation’s largest video-medicine provider, with backing from Andreessen Horowitz, Venrock, Google Ventures, and Qualcomm.
Kal founded and built Amgen’s Digital Health business unit where he had end-to-end responsibility for developing and commercializing a portfolio of digital products in connected devices, advanced algorithms/decision making and next-generation marketing, where he launched multiple regulated devices.
Prior to his focus on digital health at Amgen, Kal was the Global Marketing Lead for Enbrel, the company’s leading drug with over $6B in sales, where he created and launched major investments in novel clinical trials, innovative drug delivery devices, improved formulations and differentiated patient support programs. Kal started his Amgen career as Head of Corporate Strategy.
Kal also spent several years at Novartis Pharmaceuticals in various sales, marketing and account leadership roles. He began his professional career at the Boston Consulting Group where he worked for a broad portfolio of healthcare companies across the U.S. and Europe. He transferred to the company’s Budapest office as part of BCG’s prestigious Ambassador program and was promoted early to Principal. Kal has also served as a Senior Advisor in Digital Health to the Boston Consulting Group where he helped C-level executives at pharma and Medtech companies develop and execute digital health strategies.